No Data
Election Watch: Will Conservatives and Liberals Move the Meter With Their Stock Picks?
Eli Lilly, Novo Are Weight-Loss Winners. Rivals Won't Be an Issue for Years: Analyst. -- Barrons.com
Express News | Novo's Weight-Loss Drug Wegovy Receives UK Nod For Heart Disease
Market Whales and Their Recent Bets on LLY Options
Time for Healthcare ETFs?
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts